Anti-PMP22 antibodies in patients with inflammatory neuropathy

Journal of Neuroimmunology

Volumn 104, Issue 2, 2000, Pages 139-146

  Gabriel, C M ^a   Gregson, N A ^a   Hughes, R A C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antibodies; Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP); Guillain Barre syndrome (GBS); Inflammatory neuropathy; Peripheral myelin protein 22 (PMP22)

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MYELIN PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODIES; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CAUDA EQUINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYELIN PROTEINS; POLYNEUROPATHIES; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 0034193040     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00269-6     Document Type: Article

References (41)

1. Research criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 41:1991;617-618.
2. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27:1990;S21-S24.
3. Avrameas S. Natural autoantibodies: from "horror autoxicus" to "gnothi saeuton" Immunol. Today. 12:1991;154-159.
4. Dalakas M.C. Intravenous immune globulin for neurologic diseases. Ann. Intern. Med. 126:1997;721-730.
5. Ellie E., Vital A., Steck A., Boiron J., Vital C., Julien J. Neuropathy associated with benign anti-myelin-associated glycoprotein IgM gammopathy. Clinical, immunological, neurophysiological and pathological findings and response to treatment in 33 cases. J. Neurol. 243:1996;34-43.
6. Gabriel J.M., Erne B., Miescher G.C., Muller S.L., Vital A., Vital C., Steck A. Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteineimic neuropathies. Brain. 16:1996;775-787.
7. Gabriel C.M., Gregson N.A., Redford E.J., Davies M., Smith K., Hughes R.A.C. Human immunoglobulin ameliorates rat experimental autoimmune neuritis (EAN). Brain. 120:1997;1533-1540.
8. Gabriel C.M., Hughes R.A.C., Moore S.E., Smith K.J., Walsh F.S. Induction of experimental autoimmune neuritis with peripheral myelin protein-22. Brain. 121:1998;1895-1902.
9. Gregson N.A., Jones D., Thomas P.K., Willison H.J. Acute motor neuropathy with antibodies to GM1 ganglioside. J. Neurol. 238:1991;447-451.
10. Hadden R.D.M., Cornblath D.R., Hughes R.A.C., Zeilasek J., Hartung H.-P., Toyka K.V., Swan A.V. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann. Neurol. 44:1998;780-788.
11. Hahn A.F., Feasby T.E., Wilkie L., Lovgren D. P2-peptide induced experimental allergic neuritis: a model to study axonal degeneration. Acta Neuropathol. 82:1991;60-65.
12. Harvey G.K., Schindhelm K., Pollard J.D. IgG immunoadsorbtion in experimental allergic neuritis: effects on antibody levels and clinical course. J. Neurol. Neurosurg. Psychiatry. 52:1989;865-870.
13. Harvey G.K., Schindhelm K., Antony J.H., Pollard J.D. Membrane plasma exchange in EAN: effects on antibody levels and clinical course. J. Neurol. Sci. 88:1988;207-218.
14. Hays A.P., Latov N., Takatsu M., Sherman W.H. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology. 37:1987;242-256.
15. Ho T.W., Hsieh S.T., Nachamkin I., Willison H.J., Sheikh K., Kiehlbauch J., Flanigan K., McArthur J.C., Cornblath D.R., McKhann G.M., Griffin J.W. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology. 48:1997;717-724.
16. Ho T.W., Willison H.J., Nachamkin I., Li C.Y., Veitch J., Ung H., Wang G.R., Lui R.C., Cornblath D.R., Asbury A.K., Griffin J.W., McKhann G.M. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann. Neurol. 45:1999;168-173.
17. Hughes R.A.C., Powell H.C., Braheny S.L., Brostoff S.W. Endoneurial injection of antisera to myelin antigens in Guillain-Barré syndrome. Muscle Nerve. 8:1985;522.
18. Jacobs B.C., van Doorn P.A., Groeneveld J.H.M., Tio-Gillen A.P., van der meche F.G. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry. 62:1997;641-643.
19. Kadlubowski M., Hughes R.A.C. Identification of the neuritogen responsible for experimental allergic neuritis. Nature. 277:1979;140-141.
20. Khalili-Shirazi A., Atkinson P., Gregson N., Hughes R.A.C. Antibody responses to P0 and P2 myelin proteins in Guillain Barré syndrome and chronic idiopathic demyelinating polyradiculopathy. J. Neuroimmunol. 46:1993;245-251.
21. Koehler N.K.U., Martin R., Wietholter H. The antibody repertoire in experimental allergic neuritis: evidence for PMP-22 as a novel neuritogen. J. Neuroimmunol. 71:1996;179-189.
22. Koski C.L., Gratz E., Sutherland J., Mayer R.F. Clinical correlation with antiperipheral-nerve myelin antibodies in Guillain-Barré syndrome. J. Neuroimmunol. 19:1986;573-577.
23. Melendez-Vasquez C., Redford J., Choudhary P.P., Gray I.A., Maitland P., Gregson N.A., Smith K.J., Hughes R.A.C. Immunological investigation of chronic inflammatory demyelinating polyradiculopathy. J. Neuroimmunol. 73:1997;124-134.
24. Milner P., Lovelidge G.A., Taylor W.A., Hughes R.A.C. P0 myelin protein produces experimental allergic neuritis in Lewis rats. J. Neurol. Sci. 79:1987;275-285.
25. Olee T., Weise M., Powers J., Brostoff S.W. A T cell epitope for experimental allergic neuritis is an amphipathic alpha helical structure. J. Neuroimmunol. 21:1989;235-240.
26. Oomes P.G., Jacobs B.C., Hazenberg M.P.H., van der meche F.G., van Der Meche F.G.A. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry. Ann. Neurol. 38:1995;170-175.
27. Pestronk A., Choksi R. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology. 49:1997;1289-1292.
28. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet. 349:1997;225-230.
29. Quarles R.H., Ilyas A.A., Willison H.J. Antibodies to gangliosides and myelin proteins in Guillain-Barré syndrome. Ann. Neurol. 27:1990;S48-52.
30. Rees J.H., Gregson N.A., Hughes R.A.C. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol. 38:1995;809-816.
31. Roberts M., Willison H.J., Vincent A., Newsom-Davis J. Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann. Neurol. 38:1995;111-118.
32. Rostami A.M., Ventura E., Kimura H., Brown M.J., Pleasure D.E. Induction of severe experimental allergic neuritis with a synthetic peptide corresponding to the 53-78 amino acid sequence of the myelin P2 protein. Neurology. 38:1988;375.
33. Santoro M., Uncini A.C.M., Staugaitis S.M., Thomas F.P., Hays A.P., Latov N. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann. Neurol. 31:1998;385-390.
34. Sato S., Baba H., Inuzuka T., Miyatake T. Anti-myelin-associated glycoprotin in sera from patients with demyelinating diseases. Acta Neurol. Scand. 74:1986;115-120.
35. Schwartz M., Sela B.A., Eshhar N. Antibodies to ganglioside and myelin autoantigens are produced in mice following sciatic nerve injury. J. Neurochem. 38:1982;1182-1195.
36. Tatum A.H. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein antibody. Ann. Neurol. 33:1993;506.
37. Van der Meché F.G., Schmitz P.I. A randomised trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. New Engl. J. Med. 326:1992;1123-1129.
38. Willison H.J., Veitch J. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J. Neuroimmunol. 50:1994;159-165.
39. Willison H.J., Trapp B.D., Bacher J., Dalakas M., Griffin J.W. Demyelination induced by intraneural injection of human anti-myelin-associated glycoprotein antibodies. Muscle Nerve. 11:1988;1169-1176.
40. Wirguin I., Rosoklija G., Trojaborg W., Hays A.P., Latov N. Axonal degeneration accompanied by conduction block induced by toxin mediated immune reactivity to GM1 ganglioside in rat nerves. J. Neurol. Sci. 130:1995;17-21.
41. Yuki N. Anti-ganglioside antibody and neuropathy: review of our research. J. Periph. Nerv. Sys. 3:1998;3-18.